SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-14-003199
Filing Date
2014-03-31
Accepted
2014-03-31 08:36:05
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2219393z10-k.htm 10-K 1175096
2 EX-10.7 a2219393zex-10_7.htm EX-10.7 610528
3 EX-23.1.1 a2219393zex-23_11.htm EX-23.1.1 2994
4 EX-31.1.1 a2219393zex-31_11.htm EX-31.1.1 8200
5 EX-31.2.1 a2219393zex-31_21.htm EX-31.2.1 8204
6 EX-32.1.1 a2219393zex-32_11.htm EX-32.1.1 5433
13 G913035.JPG g913035.jpg GRAPHIC 62711
  Complete submission text file 0001047469-14-003199.txt   10129099

Data Files

Seq Description Document Type Size
7 EX-101.INS osir-20131231.xml EX-101.INS 1263752
8 EX-101.SCH osir-20131231.xsd EX-101.SCH 86163
9 EX-101.CAL osir-20131231_cal.xml EX-101.CAL 95155
10 EX-101.DEF osir-20131231_def.xml EX-101.DEF 350330
11 EX-101.LAB osir-20131231_lab.xml EX-101.LAB 1355120
12 EX-101.PRE osir-20131231_pre.xml EX-101.PRE 645254
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32966 | Film No.: 14727932
SIC: 2836 Biological Products, (No Diagnostic Substances)